About

The only company in healthcare with
exclusive access
to a decade of patient acquisition data.

Operationally generated. First-party. Condition-confirmed. Licensed exclusively for 20 years.

Get in touch ↗ View Resources ↗

Company Origin

Built operationally.
Licensed exclusively.

Squyr is the licensee of a 20-year exclusive dataset built operationally by three healthcare patient acquisition businesses. The team behind the data is the team running the company.

For a decade, three operating entities ran condition-specific patient acquisition campaigns across diabetes, sleep apnea, obesity, cardiac, and adjacent conditions. The data they generated was the operational byproduct of running those campaigns. Each entity held its own piece of the funnel.

In 2026, those operating entities collectively granted Squyr an exclusive license to the de-identified data layer across all three businesses. Squyr holds the commercial relationship; the source entities continue operating. The license runs from 2026 through 2046.

Combined with the Squyr protocol and the Squyr Exchange platform, Squyr operates as a vertically integrated patient acquisition company.

15.3M+
T3 Records
Condition-confirmed patient acquisition records, operationally generated
20yr
Exclusive License
2026–2046, covering all three operating entities and their data layers
3
Operating Entities
Each a category leader in its condition vertical. All continuing to operate.
3
Platform Layers
Data layer, Squyr protocol, and Squyr Exchange — end-to-end

Philosophy

Three principles everything
else is derived from.

01
Data quality is operational
Patient data that actually means something comes from running campaigns that generate real responses — not from surveys, panels, or third-party propagation. Every record in our dataset was produced by someone who took an action. That action is the signal.
No proxies. No modeling. No inference.
02
Bilateral exchange is the only honest structure
Third-party data companies are middlemen between the party that generated the data and the party that wants to use it. Both parties take on risk they can't fully account for. Bilateral exchange — where the two parties interact directly, in a cryptographically enforced protocol — eliminates the middleman's liability and the asymmetry.
Squyr is the implementation. Not a feature.
03
Exclusive access is the only defensible position
A dataset that competitors can also buy is a commodity. A commodity data business competes on price, which compresses margins, which reduces investment, which degrades quality. Exclusive access changes the dynamics: we can invest in the data, the platform, and the protocol because our position is protected.
The license runs 20 years. We'll act like it.

Team

The team behind the data
is the team running the company.

JA
Jake Arnold
President & Co-Founder
20 years building patient acquisition infrastructure in healthcare media. Led sales during the rise of one of the largest healthcare-vertical ad networks online, then ran sales at a category leader in pharma DTC media buying. Founded his company in 2015 to operate at the intersection of healthcare consumer acquisition and direct-response strategy — work that produced the partnerships and operating relationships that became Squyr's underlying data foundation. At Squyr, Jake leads commercial strategy, partnerships, and the platform architecture that turns a decade of operationally-generated patient records into an addressable audience layer. He also owns Provocateur Gallery in Park City, where he lives with his three sons.
GP
Greg Peyser
CEO
A two-time founder, two-time exited operator, and eight-time investor across seed and venture stages. Started his career as a G-10 spot currency trader at Barclays Capital and as a credit derivatives broker at Creditex and Phoenix Partners Group during the post-2008 derivatives market reconstruction. Shifted to operating roles, running supply chain at Suja Juice through growth from $700K to $80M+ in annual revenue. Co-founded brekki (first-to-market ready-to-eat overnight oats, sold to Cedar's Mediterranean Foods in 2019). Has invested across consumer products, biomaterials, fitness, and financial technology — including Newlight Technologies, Betterment, Lume Cube, Zeno Gym, and Barry's. At Squyr, Greg leads the company as CEO.
JS
Jordan Soblick
COO & Co-Founder
The operator behind the data. 18+ years building and running healthcare patient acquisition businesses. VP of Marketing at Verus Healthcare (CPAP supplier, acquired by AdaptHealth in 2018), where he built the digital acquisition platform that enrolled 25,000+ sleep apnea patients in 18 months. Today Managing Partner & COO of Specialty Medical Equipment, a national mail-order provider of diabetic testing supplies serving 50,000+ patients. Founded GoHealth360 in 2016 — a direct-response marketing engine specializing in diabetes and sleep health verticals, with clients including PillPack and Divvy Dose Pharmacy. Co-founded Sleep8, a medical device manufacturer where he holds two issued patents. The operating entities Jordan runs are the source of the patient acquisition data Squyr licenses exclusively.

Get in Touch

Three paths to a conversation.

Brands
Scope a license.
The fastest path is a focused conversation about your condition. We'll scope a license structure and walk through match rates and cohort sizing.
Agencies
Multi-brand relationships.
Squyr operates as the unbranded sponsor entity for unbranded campaign work that brand clients cannot run directly. Multi-brand relationships across the full data layer are available.
Partners
Open to structures.
Squyr's data is exclusive. The platform is operational. The protocol is proprietary. We're open to partnership structures depending on what you're building.
info@summitaudiencesegments.com ↗